Author:
Sandström M,Johansson M,Andersson U,Bergh A,Bergenheim A T,Henriksson R
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Abdulrauf SI, Edvardsen K, Ho KL, Yang XY, Rock JP, Rosenblum ML (1998) Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma. J Neurosurg 88: 513–520
2. Aprelikova O, Pajusola K, Partanen J, Armstrong E, Alitalo R, Bailey SK, McMahon J, Wasmuth J, Huebner K, Alitalo K (1992) FLT4, a novel class III receptor tyrosine kinase in chromosome 5q33-qter. Cancer Res 52: 746–748
3. Bergenheim A, Elfversson J, Gunnarsson P-O, Edman K, Hartman M, Henriksson R (1994) Cytotoxic effect and uptake of estramustine in a rat glioma model. Int J Oncol 5: 293–299
4. Bonomi P (2003) Clinical studies with non-iressa EGFR tyrosine kinase inhibitors. Lung Cancer 41 (Suppl 1): S43–S48, doi: 10.1016/S0169-5002(03)00141-7
5. Checkley D, Tessier JJ, Kendrew J, Waterton JC, Wedge SR (2003) Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours. Br J Cancer 89: 1889–1895, doi:10.1038/sj.bjc.6601386
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献